Fate Therapeutics (FATE) Other Working Capital Changes (2012 - 2026)

Fate Therapeutics (FATE) has 10 years of Other Working Capital Changes data on file, last reported at $200000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 210.5% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $369000.0 (up 167.34% YoY) and the FY2025 annual result came in at -$12000.0, up 98.65% from the prior year.
• Other Working Capital Changes slipped to $200000.0 in Q1 2026, from $377000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.4 million in Q4 2022 to a low of -$11.9 million in Q1 2023.
• A 5-year average of -$299647.1 and a median of $57000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 399.38% — and 2023, when it plunged 1057.79%.
• Tracing FATE's Other Working Capital Changes over 5 years: stood at -$5.4 million in 2022, then surged by 92.16% to -$425000.0 in 2023, then jumped by 51.29% to -$207000.0 in 2024, then soared by 282.13% to $377000.0 in 2025, then slumped by 46.95% to $200000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $200000.0 (Q1 2026), $377000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.